Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2003
05/14/2003EP1309593A2 Substituted pyrazoles
05/14/2003EP1309591A2 Substituted pyrazoles
05/14/2003EP1309590A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309577A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309566A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
05/14/2003EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/14/2003EP1309563A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309549A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia
05/14/2003EP1309374A2 Methods and compositions for treating ige-related disease using nnt-1 inhibitors
05/14/2003EP1309355A1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties
05/14/2003EP1309349A2 Pharmaceutical composition and method for the treatment of retroviral infections
05/14/2003EP1309337A2 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage
05/14/2003EP1309331A2 Medicine for fighting against sexual dysfunction
05/14/2003EP1309329A2 Therapeutic combination of a cetp inhibitor and atorvastatin
05/14/2003EP1309325A1 Anticonvulsant derivatives useful for the treatment of depression
05/14/2003EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
05/14/2003EP1248618A4 Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl
05/14/2003EP1233953B1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same
05/14/2003EP1192170B1 Propargyl phenyl ether a2a receptor agonists
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003EP1165595B1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
05/14/2003EP1140987B1 Peptides for inhibiting hpv e6 proteins
05/14/2003EP1140888B1 Optical molecular sensors for cytochrome p450 activity
05/14/2003EP1140189B1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
05/14/2003EP1112266B1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
05/14/2003EP1109790B1 1, 2, 4-triazole-3-thione compounds
05/14/2003EP1102746B1 Substituted phenylamidines with antithrombotic action
05/14/2003EP1068208B1 Azatricyclo[3.3.1.1] decane derivatives and pharmaceutical compositions containing them
05/14/2003EP1045842B1 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
05/14/2003EP1042317B1 Indole derivatives as PKC-inhiboitors
05/14/2003EP1036095A4 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
05/14/2003EP0954521B1 4- (thien-3-yl)methyl] imidazole derivatives having alpha2-adrenoceptor agonistic activity
05/14/2003EP0932609B1 AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO 2,3-e]INDOL-8-ONE
05/14/2003EP0915869B1 Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/14/2003EP0873330B1 Diarylalkenylamine derivatives
05/14/2003EP0815255B1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
05/14/2003EP0797427B1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides
05/14/2003EP0769945B1 Use of 2-phenyl-3-aroylbenzothiophene derivatives for the manufacture of a medicament for bone healing and fracture repair
05/14/2003EP0749308B1 Film coated tablet of paracetamol and domperidone
05/14/2003CN1418255A Herpes virus strains for gene therapy
05/14/2003CN1418253A Proteins producing altered immunogenic response and methods of making and using the same
05/14/2003CN1418219A Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the prepararation of the derivatives
05/14/2003CN1418217A Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof
05/14/2003CN1418216A Novel 2,3,4,5-tetrahydro-1H-[1,4] diazepino [1,7a]indole compound
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418214A 4-Hydroxy-1, 8-Naphthyridine-3-carboxamides as antiviral agents
05/14/2003CN1418211A 苯并咪唑衍生物 Benzimidazole derivatives
05/14/2003CN1418209A Carbocyclic side chain containing metalloprotease inhibitors
05/14/2003CN1418207A Agents correcting gene expression regulatory error
05/14/2003CN1418203A Percyquinnin, Process for its production and its use pharmaceutical
05/14/2003CN1418199A Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
05/14/2003CN1418198A Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulfonyl)amino] pyrimidin-5-yl]-(3R5S)-3,5-dihydroxyhept-6-enojc acid
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418196A Pyridazinyl phenyl hydrazones useful against congestive heart failure
05/14/2003CN1418195A Therapeutic morpholino-substituted compounds
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418190A N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418185A Aniline-derived ligands for thyroid receptor
05/14/2003CN1418121A Compound with 5-HT1A activity useful for treating disorders of outer retina
05/14/2003CN1418111A Novel Ligands and method for preparing same
05/14/2003CN1418106A 疫苗 Vaccine
05/14/2003CN1418104A Cosmetic use of hop and ornithine
05/14/2003CN1418101A Method of increasing alertness by administration of vomeropherin and vomeropherin-emitting alarm device
05/14/2003CN1418100A Compounds with 5-HT activity useful for controlling visual field loss
05/14/2003CN1418099A Choice compound for treatment of fibromyalgia and chronic fatigue syndrome
05/14/2003CN1418098A Tamper-resistant oral opioid agonist formulations
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1418094A Use of deramciclane for treatment of anxiety and depression
05/14/2003CN1418089A Pharmaceutical composition of glycogen phosphorylase inhibitors
05/14/2003CN1417217A New oligosaccharides and its prepn
05/14/2003CN1416893A Medicine containing recombinant human metallothionein and its prepn
05/14/2003CN1416860A Prepn process of life prolonging tablet
05/14/2003CN1416852A Active matter for preventing and treating cerebral diseases and promoting intelligence growth and its prepn
05/14/2003CN1416832A Medicine pill for changing sex chromosome
05/14/2003CN1416806A Local composition with undifferentiated plant seed cell and ifs usage
05/14/2003CN1108301C Inhibitors of microsomal triglyceride transfer protein and mothed
05/14/2003CN1108290C Urea derivatives
05/14/2003CN1108159C Traditional Chinese medicine for curing diabetes and kidney deficiency
05/14/2003CN1108153C Oral compositions containing ondansetron
05/13/2003WO2002040048A2 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
05/13/2003US6563002 Biscyclopropanecarboxamide compounds and pharmaceutical use thereof
05/13/2003US6562988 16-HETE (16-hydroxyeicosatetraenoic acid) analogues such as the methanesulfonamide ester (-CO-NH-SO2-CH3); inhibiting neutrophil adhesion and neutrophil aggregation; treating stroke, inflammatory diseases
05/13/2003US6562980 Method for producing 5-aryloxymethyl-2-oxazolidinones
05/13/2003US6562978 N-(3-(4-(4-(Aminocarbonyl)benzyl)-1-piperidinyl)propyl)-N-(3, 4-dichlorophenyl)-1-(methylsulfonyl)-4-piperidinecarboxamide or a salt thereof for treatment of AIDS
05/13/2003US6562963 Coupling using organosilicon compound
05/13/2003US6562950 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions
05/13/2003US6562873 Containing oxy-chloro components including chlorine dioxide, hypochlorite, perchlorate or chlorite components
05/13/2003US6562868 Method of treating female sexual dysfunction, comprising administering to a human a therapeutically effective and physiologically acceptable amount of a prostaglandin selected from the group consisting of 19-hydroxy-PGE2,
05/13/2003US6562864 Catechin multimers as therapeutic drug delivery agents
05/13/2003US6562862 Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
05/13/2003US6562861 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
05/13/2003US6562857 Cyanopyrroles
05/13/2003US6562855 Comprises a formulation. The formulation comprises an NMDA antagonist and an alpha-2 adrenergic agonist. In a preferred aspect, there is provided an improved anaesthetic comprising an NMDA antagonist and an alpha-2 adrenergic agonist.
05/13/2003US6562849 Amine compound or pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc.
1 ... 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 ... 1564